Esperion Therapeutics
ESPR
#6048
Rank
$0.49 B
Marketcap
$2.68
Share price
2.29%
Change (1 day)
52.27%
Change (1 year)

P/S ratio for Esperion Therapeutics (ESPR)

P/S ratio as of March 2024 (TTM): 4.26

According to Esperion Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 4.26309. At the end of 2023 the company had a P/S ratio of 2.92.

P/S ratio history for Esperion Therapeutics from 2013 to 2023

PS ratio at the end of each year

Year P/S ratio Change
20232.92-51.95%
20226.0856.69%
20213.8831.08%
20202.96-73.21%
201911.1
2018N/A
2017N/A
2016N/A
2015N/A
2014N/A
2013N/A

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
2.69-36.99%๐Ÿ‡บ๐Ÿ‡ธ USA
8.09 89.84%๐Ÿ‡บ๐Ÿ‡ธ USA
8.85 107.66%๐Ÿ‡บ๐Ÿ‡ธ USA
> 1000 26,006.42%๐Ÿ‡บ๐Ÿ‡ธ USA
8.71 104.38%๐Ÿ‡บ๐Ÿ‡ธ USA
6.91 62.14%๐Ÿ‡บ๐Ÿ‡ธ USA